June 19, 2017Circulation

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization

View Full Paper

Ask AI

Bookmark

Why the study?

Does antithrombotic therapy improve outcomes in patients with peripheral artery disease undergoing revascularization?

Population

Patients with peripheral artery disease undergoing limb revascularization

Design

Review

Authors

CHConnie N. HessUniversity of Colorado Denver LNLars NorgrenVascular / Pulmonary Vascular GAGary M. AnselClinical Insights

Discussion

Member takes

Implication

Leaves open optimal antithrombotic regimens after PAD revascularization; supports prioritizing RCTs to strengthen guidelines.

Structured PICO

Does antithrombotic therapy improve outcomes in patients with peripheral artery disease undergoing revascularization?

Population

Patients with peripheral artery disease (intermittent claudication or critical limb ischemia) undergoing limb revascularization

Intervention

Antithrombotic therapy (antiplatelet and anticoagulant therapies)

This review highlights the critical lack of high-quality randomized evidence for antithrombotic therapy following peripheral artery revascularization, noting that current practices are largely extrapolated from coronary interventions.

Cite This Study

Hess et al. (2017) studied this question.

synapsesocial.com/papers/69fa8811bb4cae3c76412eb7 https://doi.org/10.1161/circulationaha.117.024469

View Full Paper

Ask AI

Bookmark

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization

Discussion

Member takes

Implication

Structured PICO

Cite This Study

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider